Determining a NOAEL for the consortium linking academic and regulatory insights on BPA toxicity (CLARITY-BPA) core study
The CLARITY-BPA Core Study is the most comprehensive animal study of oral bisphenol A (BPA) exposure to date. Rats were exposed daily, in utero until postnatal day 21 or for the animals’ lifetime. While the study authors concluded that several observations at the highest dose may be BPA treatment-re...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Toxicology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/ftox.2025.1639737/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849231582734319616 |
|---|---|
| author | Melissa Badding Noor Aly Kevin Sondenheimer |
| author_facet | Melissa Badding Noor Aly Kevin Sondenheimer |
| author_sort | Melissa Badding |
| collection | DOAJ |
| description | The CLARITY-BPA Core Study is the most comprehensive animal study of oral bisphenol A (BPA) exposure to date. Rats were exposed daily, in utero until postnatal day 21 or for the animals’ lifetime. While the study authors concluded that several observations at the highest dose may be BPA treatment-related, a No-Observed-Adverse-Effect Level (NOAEL) has not been proposed in the published reports. Therefore, select endpoints deemed by the study authors to be potentially BPA treatment-related were further evaluated to determine a NOAEL. These include findings in the female reproductive tract and male pituitary gland at the highest dose level (25,000 μg/kg-bw/day). The data were examined for dose-response, relevance, and consistency of findings across study arms and timepoints, histopathological progression, and concordance with the estradiol positive control. Based on our evaluation, some of the female reproductive tract findings are possibly BPA treatment-related. However, there is a lack of consistency between study arms and/or timepoints, no significant dose-response, and a lack of progression to tumors for proliferative findings. Finally, the findings from the Core Study agree with previous high-quality guideline studies which determined that BPA did not pose adverse effects at doses below 25,000 μg/kg-bw/day in rodents. Altogether, some findings from the Core Study may be BPA treatment-related but they should not be considered adverse. Therefore, we hypothesize that the NOAEL from the Core Study is reasonably considered to be 25,000 μg/kg-bw/day. |
| format | Article |
| id | doaj-art-9eb27f4d802a44e6b38b0c45a218ea75 |
| institution | Kabale University |
| issn | 2673-3080 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Toxicology |
| spelling | doaj-art-9eb27f4d802a44e6b38b0c45a218ea752025-08-21T05:27:25ZengFrontiers Media S.A.Frontiers in Toxicology2673-30802025-08-01710.3389/ftox.2025.16397371639737Determining a NOAEL for the consortium linking academic and regulatory insights on BPA toxicity (CLARITY-BPA) core studyMelissa Badding0Noor Aly1Kevin Sondenheimer2Exponent, Inc., Alexandria, VA, United StatesExponent, Inc., Alexandria, VA, United StatesCovestro Deutschland AG, Leverkusen, GermanyThe CLARITY-BPA Core Study is the most comprehensive animal study of oral bisphenol A (BPA) exposure to date. Rats were exposed daily, in utero until postnatal day 21 or for the animals’ lifetime. While the study authors concluded that several observations at the highest dose may be BPA treatment-related, a No-Observed-Adverse-Effect Level (NOAEL) has not been proposed in the published reports. Therefore, select endpoints deemed by the study authors to be potentially BPA treatment-related were further evaluated to determine a NOAEL. These include findings in the female reproductive tract and male pituitary gland at the highest dose level (25,000 μg/kg-bw/day). The data were examined for dose-response, relevance, and consistency of findings across study arms and timepoints, histopathological progression, and concordance with the estradiol positive control. Based on our evaluation, some of the female reproductive tract findings are possibly BPA treatment-related. However, there is a lack of consistency between study arms and/or timepoints, no significant dose-response, and a lack of progression to tumors for proliferative findings. Finally, the findings from the Core Study agree with previous high-quality guideline studies which determined that BPA did not pose adverse effects at doses below 25,000 μg/kg-bw/day in rodents. Altogether, some findings from the Core Study may be BPA treatment-related but they should not be considered adverse. Therefore, we hypothesize that the NOAEL from the Core Study is reasonably considered to be 25,000 μg/kg-bw/day.https://www.frontiersin.org/articles/10.3389/ftox.2025.1639737/fullbisphenol A (BPA)CLARITY-BPAno-observed-adverse-effect level (NOAEL)risk assessmentreproductive toxicity |
| spellingShingle | Melissa Badding Noor Aly Kevin Sondenheimer Determining a NOAEL for the consortium linking academic and regulatory insights on BPA toxicity (CLARITY-BPA) core study Frontiers in Toxicology bisphenol A (BPA) CLARITY-BPA no-observed-adverse-effect level (NOAEL) risk assessment reproductive toxicity |
| title | Determining a NOAEL for the consortium linking academic and regulatory insights on BPA toxicity (CLARITY-BPA) core study |
| title_full | Determining a NOAEL for the consortium linking academic and regulatory insights on BPA toxicity (CLARITY-BPA) core study |
| title_fullStr | Determining a NOAEL for the consortium linking academic and regulatory insights on BPA toxicity (CLARITY-BPA) core study |
| title_full_unstemmed | Determining a NOAEL for the consortium linking academic and regulatory insights on BPA toxicity (CLARITY-BPA) core study |
| title_short | Determining a NOAEL for the consortium linking academic and regulatory insights on BPA toxicity (CLARITY-BPA) core study |
| title_sort | determining a noael for the consortium linking academic and regulatory insights on bpa toxicity clarity bpa core study |
| topic | bisphenol A (BPA) CLARITY-BPA no-observed-adverse-effect level (NOAEL) risk assessment reproductive toxicity |
| url | https://www.frontiersin.org/articles/10.3389/ftox.2025.1639737/full |
| work_keys_str_mv | AT melissabadding determininganoaelfortheconsortiumlinkingacademicandregulatoryinsightsonbpatoxicityclaritybpacorestudy AT nooraly determininganoaelfortheconsortiumlinkingacademicandregulatoryinsightsonbpatoxicityclaritybpacorestudy AT kevinsondenheimer determininganoaelfortheconsortiumlinkingacademicandregulatoryinsightsonbpatoxicityclaritybpacorestudy |